| Human Molecular Genetics | Pages |
Isolation and embryonic expression of the novel mouse gene Hic1, the homologue of HIC1, a candidate gene for the Miller-Dieker syndrome
Introduction
Results
Isolation of the murine Hic1 and its genomic structure
Deduced amino acid sequence and domain structure
Chromosomal localization of Hic1
Expression of the murine Hic1 mRNA
Hic1 expression in sclerotomal and body wall mesenchymes
Expression of Hic1 in limb and cranio-facial mesenchymes
Expression of Hic1 in mesenchymes facing epithelia of inner organs
Discussion
Genomic organization of murine Hic1
Chromosomal localization of Hic1
Comparison of the expressions of Hic1 and [gamma]FBP during development
Hic1 is expressed in perineural mesenchymes
Hic1 is activated in embryonic anlagen of tissues that are affected in MDS patients
Materials And Methods
Animals and embryos
Expressed sequence tags
Isolation of the murine Hic1
Northern analysis
Chromosomal localization
In situ hybridization
Acknowledgements
Abbreviations
Note added in proof
References
Isolation and embryonic expression of the novel mouse gene Hic1, the homologue of HIC1, a candidate gene for the Miller-Dieker syndrome
DDBJ/EMBL/GenBank accession nos AF036582, AF036334, AF111712
INTRODUCTION
HIC1 (hypermethylated in cancer) (1) resides in the Miller-Dieker syndrome (MDS) critical region on human chromosome 17p13.3. HIC1 encodes a C2-H2 zinc-finger protein with a poxvirus and zinc-finger (POZ) domain. The POZ domain, also known as broad complex, tramtrack, bric à brac (BTB) or zinc-finger N-terminal region (ZIN) domain, is a hydrophobic, ~120 amino acid protein-protein interaction motif that is generally found at the N-terminus of either actin binding or DNA binding proteins. All tested POZ-C2-H2 zinc-finger proteins act as transcription factors. Several POZ proteins are localized in specific dots within the nucleus. Some POZ proteins have been implicated in chromatin remodeling (1,2; reviewed in ref. 3). HIC1 is a potential tumor suppressor gene since it is hypermethylated and its expression is downregulated in several common types of cancer (4). Moreover, loss of heterozygosity at the HIC1 locus was observed e.g. in medulloblastoma and lung cancers (5,6 and references therein).
MDS (OMIM 247200) is a severe genetic disorder caused by hemizygous deletion of a critical region in 17p13.3, indicating haploinsufficiency of the involved genes. The syndrome is characterized by lissencephaly type I (smooth brain, agyria, pachygyria), characteristic facial appearence, and occasionally additional birth defects (7-11). Many patients die within the first few years of life (9). Lissencephaly has also been observed without facial dysmorphism, and was referred to as isolated lissencephaly (ILS). The type I lissencephaly observed in ILS and MDS is caused by deletions or mutations of the LIS1/PAFAH1B1 gene (12-15) that codes for the 45 kDa subunit of the platelet activating factor acetylhydrolase (16). The deletions observed in MDS always include LIS1/PAFAH1B1 and other telomeric loci (13,17). At least four genes reside in this region, these are MNT/ROX (encoding the MAX-interactor protein) at D17S379 (18,19), OVCA1/DPH2L and OVCA2 at D17S28/YNH37 (20,21) and HIC1 at D17S5/YNZ22 (4).
a
![]() |
b
![]() |
Figure 1. Analysis of the murine Hic1 gene. (a) Isolation of the murine Hic1 gene. The relative sizes and locations of the murine Hic1 EST (IMAGE Consortium CloneID 337 300), two Hic1 cDNA clones (7-3-3 and 6-1) and the genomic Hic1 clone (G6-2) are given schematically. The exons are boxed and the intron is drawn as a line. The region encoding the POZ-domain is shaded and the region encoding the five zinc fingers is indicated by zf. A potential TATA-box, the putative start codon, the stop codon and the poly(A) signal are indicated. For comparison, the human genomic HIC1 clone (accession no. L41919) (4) and a human EST (IMAGE Consortium CloneID 1520744, accession no. AA91086) are included. Human HIC1 was localized ~2-3 kb centromeric to the marker YNZ22 (4). The dashed line represents unknown sequence and is not drawn into scale. In addition, the position of the short human genomic fragment (accession no. M21147) is indicated. This fragment was placed ~1.8 kb centromeric to the marker YNZ22 (33). (b) Northern blot analysis of total RNA from adult lung. The blot was probed with a fragment of Hic1 3[prime]-UTR. The positions of the 18S and 28S rRNA bands are indicated.
Figure 2. Hic1 genomic DNA and deduced amino acid sequence. The deduced amino acid sequence is shown below the nucleotide sequence of the DNA. The POZ domain is underlined and the C-terminal zinc fingers are boxed. The cluster of basic amino acids is double underlined and the GLDLSK motif is drawn in bold. The CAAT and the TATA consensus sequences are boxed. The CAAT consensus was found on the antisense strand. Presumptive recognition sites for known transcription factors in the 5[prime]-UTR are under- or overlined. The first ATG and the predicted stop codon are shown in bold letters and the consensus polyadenylation site is underlined. The intron is indicated by lower case letters. Abbreviation for transcription factors: AP, activating protein; EGR, early growth response; NF[kappa]B, nuclear factor [kappa]B; Oct, octamer-binding protein; RREB, ras responsive element binding protein, SP1, stimulating protein. The genomic Hic1 and the partial 3 kb Hic1 cDNA sequences are deposited in GenBank under accession nos AF036582 and AF036334, respectively. Here we report the isolation, genomic structure, chromosomal localization and embryonic expression of the mouse Hic1 gene. Parts of the Hic1 expression territories in the embryo overlap with regions that exhibit abnormalities in MDS patients. The evaluation of its embryonic expression and the mapping of Hic1 to mouse chromosome 11 at 48 cM will be of importance for understanding the genetic basis of MDS.
RESULTS
Isolation of the murine Hic1 and its genomic structure
For the human HIC1, a genomic clone (4) and an expressed sequence tag (EST) have been described. Screening of the EST database (dbEST) with the human HIC1 sequence identified its murine homologue. The corresponding EST clone from the IMAGE consortium (CloneID 337300) (22) encompassed 0.6 kb of 3[prime]-untranslated region (3[prime]-UTR) and was used as a probe to screen cDNA libraries (Fig.
Comparison of the genomic Hic1 and the cDNA sequences revealed two exons, separated by a 1451 nt intron (Fig.
Transcription is predicted to start at an adenine, surrounded by pyrimidines, 35 nt downstream of the TATA box (26), resulting in a predicted transcript of 3642 nt: a first exon of 665 nt and a second exon of 2977 nt. Northern analysis of total RNA from lung of adult mice revealed a single transcript of ~3.7 kb (Fig.
Deduced amino acid sequence and domain structure
The deduced Hic1 protein consists of 892 amino acids including a POZ domain and five C2-H2 zinc fingers at the C terminus (Fig.
a
![]() |
b
![]() |
Figure 3. Comparison of murine Hic1 to related proteins. (a) Alignment of the deduced amino acid sequence from the human HIC1, the murine Hic1 and the related chicken [gamma]FBP. The POZ domain and the zinc fingers are underlined. Identical amino acids are shaded in gray and similar amino acids are boxed. GenBank accession nos: human HIC1, L41919; [gamma]FBP-B, X79050. (b) Domain structure. Schematic representation of the predicted murine Hic1, human HIC1, chicken [gamma]FBP and the partial zebrafish hzp1 proteins. The percentages indicate amino acid identity of the domains as compared with murine Hic1. The DNA sequence of the zebrafish hzp1 is deposited in GenBank under accession no. AA111712. By fluorescence in situ hybridization (FISH) analysis, using the 16 kb genomic Hic1 clone G6-2 as a probe and a mouse chromosome 11 paint probe, Hic1 was localized to chromosome 11 (Fig. Figure 4. FISH on a methaphase spread with a chromosome 11 paint probe (green) and the genomic Hic1 probe (red). Chromosomes were counterstained with DAPI and banded with actinomycin D. Figure 5. Genetic mapping of the mouse Hic1 employing the EUCIB. (a) Genotype analysis. Animals were typed for Hic1 (this study) and the markers D11Mit10, D11Mit36, D11Mit31, D11Nds19 and D11Mit119 (28). Each column represents the genotype that was identified in the backcross progeny. Open boxes represent homozygous loci (C57BL/6J or M.spretus); filled boxes represent heterozygous loci; n.d., not determined. The number of progeny inheriting each genotype is entered below the column. (b) Partial EUCIB map of mouse chromosome 11. Primary anchor loci D11Mit10, D11Mit36, D11Nds19 and the secondary anchor locus D11Mit31 were typed in all backcross mice; Hic1 was analyzed in 130 animals and the microsatellite markers D11Mit38, D11Mit39, D11Mit119, D11Mit211 and D11Mit325 as well as the genes Cryba1, Cacna1g and Nfe2l1 were typed in different subsets of backcross mice. Map positions in cM of the centromere are given on the left and were calculated with the Mbx database (28). Human orthologues and their chromosomal localizations are given on the right. The spatio-temporal expression of the murine Hic1 gene during embryonic and fetal development was investigated by in situ hybridizations (ISHs) of whole mount embryos and on paraffin sections. As templates for riboprobes, the 0.6 kb EST (IMAGE Consortium CloneID 337300) (Figs Figure 6. Whole mount in situ hybridizations detecting Hic1 expression in somite derivatives and body wall of mouse embryos at TS17-20. Digoxigenin-labelled Hic1 antisense riboprobes detected expression in somite derivatives (a and b, So) that were localized to spatially separated epaxial and hypaxial mesenchymes, firstly, of the sclerotomes (a, c, d, e and g, arrowheads and ST), and later, also of the lateral body wall (d-h, lM). Epaxial and hypaxial Hic1 expressions in these territories are sharply delineated against the non-expressing mesenchyme of the intercalated, central somite derivatives (g and h, stippled lines mark central territory). Hic1 is also expressed in the limb anlagen (a, b, e, f, g and h), in cranio-facial regions (a and b, arrows, and f), and in mesenchymes associated with spinal ganglia (d, f and h, black arrows) and with skeletal condensations (f and h, VA). (a, b, c, f, g and h) Lateral views; (d and e) dorso-lateral views; (e[prime]) ventral view; (c[prime] and d[prime]) transverse cuts from TS17 and TS19 whole mount embryos, respectively. The horizontal lines connect specific aspects of the Hic1 expression pattern in lateral views of whole embryos (c and d) and transverse cuts (c[prime] and d[prime]). Rostral is to the left (except in c). The white arrows mark bright blue precipitate in the medial mesenchymes typically arising in the depth of whole embryos (d[prime] and h). AT, atlas; c, central; cer, cervical; DM, dermomyotome; e, epaxial; FL, fore limb bud; HL, hind limb bud; G, gut; h, hypaxial; mM, medial mesenchyme; lM, lateral mesenchyme; P, pancreas; SB, somitic bud; SG, spinal ganglion; So, somite derivatives; ST, sclerotome; tho, thoracic; TS, Theiler stage; VA, vertebral arch anlage. The mesenchymal sclerotomes and epithelial dermomyotomes arise from the mesodermal segments, the somites. The sclerotomes differentiate into axial skeleton and perineural mesenchymes embedding the spinal cord and trunk peripheral nerves. The dermomyotomes give rise to part of the dermis and the myotomes, progenitors of skeletal muscles (reviewed in ref. 29). Hic1 expression in somite derivatives was first restricted to stripes along their segmental borders spreading in a rostro-caudal direction (Fig. Figure 7. ISHs detecting Hic1 expression in mesenchymes surrounding peripheral nerves and limb anlagen at TS19-23. At TS19, Hic1 is expressed in epaxial and hypaxial mesenchymes directly adjacent to the still epithelial somite derivatives (including embryonic muscle anlagen) and the condensing skeletal anlagen (including rib anlagen) (a and b). Moreover, Hic1 is expressed in mesenchymes facing epithelia of inner organs [gut in (a); urogenital ridge in (b)]. At TS22, Hic1 expression is associated with epaxial and hypaxial muscles (d). Hic1 is expressed in mesenchymes surrounding the earliest condensations of the skeletal anlagen of the limb anlagen (e-h). Later, Hic1 expression is also localized to distinct rostral and caudal limb mesenchymes (f and g, arrows). In all stages, Hic1 expression is detected in mesenchymes which embed the elongating peripheral nerves (a-e, and h). Paraffin sections were cut transversally (a, d, e, e[prime] and h), sagittally (b) and horizontally (c). (e[prime]) HE-staining of a section adjacent to that shown in (e). Section planes of (f[prime]) and (h) are shown in (f) and (g), respectively. (f and g) Whole mount fetuses. e, epaxial; G, gut; GR, urogenital ridge; h, hypaxial; HL, hind limb bud; l, lateral; LP, limb plexus; m, medial; M, mesenchyme; PN, peripheral nerve; R, rib anlage; SC, skeletal condensation; SG, spinal ganglion; TS, Theiler stage. Scale bar, 200 µm. Figure 8. ISHs detecting Hic1 expression in cranio-facial mesenchymes and inner organs at TS19-22. Whole mount embryos (a, b, d and d[prime]) and paraffin sections (c, e, f, g and h) hybridized to Hic1 and, for comparison, to Col2a1 (b) and Myod1 (d[prime]). Hic1 expression in cranio-facial mesenchymes (a, c and d) is mutually exclusive to that of Col2a1 (b), and abuts or partly overlaps the muscle marker Myod1 (d[prime]). Hic1 expressing mesenchymes surround cranial peripheral nerves (a, c and e) and abut epithelial buddings, for example, of the nose (a, c and f), salivary glands (g) and caudal pharyngeal pouches [thymus in (e)]. Hic1 is also expressed in the mesenchymes of a varity of inner organs, e.g. adrenal gland and metanephric kidney (h). During early cornea development, Hic1 is transiently expressed in a ring-shaped mesenchyme (d, arrow). Section plane of (e) is shown in (a). AG, adrenal gland anlage; CN, peripheral cranial nerve; EM, external eye muscles; IE, inner ear; JM, jaw muscle; KT, kidney tubule; Md, mandibular arch; Mx, maxillar arch; No, nose; PN, peripheral nerve; Sal, salivary gland; Th, thymus anlage; Tri, trigeminus ganglion; TS, Theiler stage. Scale bar, 200µm. During maturation of somite derivatives, Hic1, in addition to its expression in epaxial and hypaxial sclerotome moieties, is activated in mesenchymes laterally to (overlying) the dermomyotomes spreading in a rostro-caudal direction (Fig. It is worth noting that the Hic1-expressing mesenchymes associated with the epaxial and hypaxial somite derivatives are sharply delineated against a non-expressing territory overlying the intercalated, central somite derivatives (Fig. At TS17-18, Hic1 expression started in limb bud mesenchymes near the dorsal and ventral surfaces (Fig. In cranio-facial mesenchymes, expression of Hic1 was detected near the joint anlage of the jaw [Figs From early fetal development onwards, Hic1 expression was detected in restricted moieties of pancreas, gut, adrenal gland, kidney anlagen and urogential ridge (Figs The novel murine Hic1 gene was isolated and characterized. Sequence analysis of the murine Hic1 gene revealed that it represents the murine orthologue of the previously described human HIC1 (4). Furthermore, Hic1 is closely related to the chicken [gamma]FBP (32) and the zebrafish hzp1 that was sequenced in this study. Hic1 is activated in embryonic anlagen of some tissues affected in MDS patients. The embryonic expression of Hic1 is in line with a phenotypic contribution of HIC1 to MDS. The comparison of the isolated mouse cDNA clones with the genomic sequence revealed that the murine Hic1 gene contains two exons, separated by a 1.5 kb intron. For the human HIC1 gene only a genomic clone was described and the exon-intron structure was predicted to have three exons (4). The presumptive first human 5[prime]-untranslated exon is not contained in the isolated murine cDNA and in a human HIC1 EST (Fig. In this study Hic1 was mapped to mouse chromosome 11 at 48 cM employing the EUCIB. Its human orthologue was placed at 17p13.3 (4). Other genes that have been localized on the EUCIB, are Cryba1 at 45 cM, Cacna1g at 60 cM and Nfe2l1 at 61 cM. However, the human orthologues of these three genes map to 17q (Fig. Sequences from the human MDS chromosomal region hybridized to mouse chromosome 11 (36). In addition, the gene order and relative distance of genes localized inside (LIS1/PAFAH1B1, MNT/ROX) and outside (14-3-3e/YWHAE) the MDS critical chromosomal region are conserved between man and mouse. The three genes reside within 1 Mb (37) and have been placed at 44 cM on the mouse chromosome 11 in the MGD map. In human, HIC1 is localized between MNT/ROX and 14-3-3e/YWHAE. For the establishment of an MDS mouse model it would be extremely important to determine the precise localization of Hic1 in relation to these genes. The POZ domain and the zinc-finger region of the murine Hic1, the human HIC1 and the chicken [gamma]FBP proteins are highly identical, thus suggesting that these proteins might exert similar functions. HIC1 is expressed in all adult tissues analysed (4), but its embryonic expression pattern is not known. Comparison of the murine Hic1 expression and that of a related gene in chicken embryos, [gamma]FBP, revealed some similarities, but also some differences. [gamma]FBP and Hic1 might share expression territories in the sclerotomes, head mesenchyme, developing extremities, pharynx, esophagus, tongue, urogenital ridge, intestine, vertebral arch and rib associated mesenchymes (32 and this study). Despite the absence of detailed information on the [gamma]FBP expression, these general similarities raise the possibility of common functions of these structurally related genes in differentiation of restricted mesenchymes. Moreover, [gamma]FBP was expressed during lens differentiation and functionally implicated in the regulation of the [gamma]F-Crystallin (Crygf) gene (32). However, we did not detect any expression of the murine Hic1 gene in lenses at embryonic, fetal, postnatal (p1, p7, p14, p21), and adult stages by means of ISHs of whole embryos and on paraffin sections (Fig. Embryonic expression of Hic1 was detected in subterritories of the sclerotomes, first intersomitically, and shortly later, in the rostral sclerotome halves. Formation of the segmental array of the components of the peripheral nervous system (PNS), the peripheral ganglia, peripheral nerves and their branches, depends on the permissive properties of the rostral sclerotome halves and the repulsive properties of the caudal sclerotome halves (38-41). Fetal expression of the Hic1 gene was observed in the mesenchymes embedding elongating peripheral nerves in the head, trunk and limbs. Moreover, the spatio-temporal dynamics of Hic1 expression appeared to reflect the course of branching in the peripheral nerves whose target regions are situated more and more peripherally (42,43). Thus, Hic1 expression might play a role in the specification of the sclerotome- and lateral plate-derived as well as cranial mesenchymes implicated in the spatial organization of the PNS. Finally, Hic1 was expressed in mesenchymes at many sites where peripheral nerves probably make contact with the developing muscles and the visceral organs. Interestingly, also the Drosophila POZ-C2-H2 zinc-finger protein lola (longitudinals lacking) plays essential roles in PNS development; lola is required for axon growth and guidance of the intersegmental nerves (44). Moreover, the Drosophila POZ-C2-H2 zinc-finger BR-C (broad complex) regulates muscle attachment in Drosophila (45). The possible contribution of the HIC1 gene to the development of peripheral nerves remains to be elaborated, because also the LIS1/PAFAH1B1 and the MNT/ROX genes may be implicated in peripheral nerve development (12,46). Moreover, in syndromes encompassing lissencephaly, it is difficult to decide if the primary reasons of functional deficiencies of the PNS reside solely in the brain or also the PNS itself. Besides lissencephaly, MDS patients exhibit facial dysmorphism and frequently additional birth defects, e.g. anomalies of the heart, kidney, gastrointestinal tract and the limbs (7-11). Genes deleted in MDS patients are from the centromere to the telomere: LIS1/PAFAH1B1, MNT/ROX, HIC1, OVCA1/DPH2L and OVCA2. In the ILS, mutations and deletions of the LIS1/PAFAH1B1 gene were observed (12-14), and in several cases, also the locus D17S379 residing in the 3[prime]-UTR of the MNT/ROX gene is deleted (10,13). However, the deletions in MDS patients always extend more distally than those in the deleted ILS patients (13). ILS patients sometimes exhibit subtle cranio-facial anomalies reminiscent of those in MDS patients, like bi-temporal hollowing and small jaw, but they rarely have other consistent anomalies (10), strongly suggesting that loss of function in the LIS1/PAFAH1B1 and MNT/ROX genes does not cause the defects in cranio-facial and limb development in MDS patients. This raises the possibility that other candidate genes in the MDS critical region may be implicated in the defects other than lissencephaly. OVCA1/DPH2L and OVCA2 contain no known functional motifs and are ubiquitously expressed in adult tissues (21) and their developmental expression is not known. In this study, we present the mouse gene Hic1, the orthologue of HIC1, and the striking correlation of its expression with additional sites of defective development in MDS patients. First, MDS patients exhibit a characteristic facial appearence consisting of a prominent forehead, small jaw (micrognathia), bi-temporal hollowing, short nose with upturned nares, a broad nasal bridge and a protuberant upper lip. Frequently, wrinkling of the forehead was also observed (9). During development, Hic1 is expressed in the first branchial arch that gives rise to the maxillar and mandibular components of the jaw and the lips. In addition, Hic1 expression was observed in the mesenchyme surrounding the infolding nasal epithelium in embryonic and fetal development. Thus, the developmental expression of Hic1 in spatially restricted cranio-facial mesenchymes whose derivatives are affected in MDS patients suggests that HIC1 may be implicated in the morphogenesis of the nose, jaw and lips. Secondly, frequently, clinodactyly and sometimes syndactyly were observed in MDS patients (9). Hic1 is expressed in restricted domains of the limb mesenchyme, surrounding the skeletal condensations, as well as in rostral and caudal mesenchymes of each digit anlagen. Thus, loss of HIC1 function may be involved in the limb anomalies observed in MDS. Thirdly, less frequently, inguinal hernia/omphalocoele was associated with MDS, leading to the suggestion that a gene involved in the closure of the lateral folds or in the return of the midgut from the body stalk to the abdomen during weeks 5-11 of gestation resides at 17p13.3 (11). Hic1 is expressed in the lateral body wall and in the gut. This raises the possibility that its human homologue might play a role in the omphalocoely observed in MDS patients. Finally, two patients with kidney defects were reported and one case with a duodenal atresia (7,8). Hic1 is expressed during development of the gut and the kidney. In conclusion, the mouse homologue of HIC1, during embryonic development, is expressed in restricted territories of facial mesenchymes (in the branchial arches, surrounding the infolding nasal epithelium and the facial nerves), in the lateral body wall, kidney, gut and limb anlagen. All these expression territories correspond to sites where developmental defects are observed in MDS patients. Therefore, alterations in the gene dosage of the putative transcription factor HIC1 might be involved in the anomalies observed in MDS patients, that are hemizygous for HIC1. An example for gene dosage effects of transcription factors is the Pax family of paired domain proteins. All analyzed heterozygous Pax null mutants exhibit severe developmental defects due to haploinsuffiency (reviewed in ref. 47). The generation and investigation of heterozygous and homozygous Hic1 knock-out mutant mice will help to reveal if the gene dosage of Hic1 is critical for development and if its human orthologue might be involved in the MDS. Mice were obtained from the GSF animal facilities. C3H/El and (102/El × C3H/El)F1 hybrid mice were used for the supply of all tissues and the preparation of embryos; for the latter also C57BL/6 mice were used. Staging of embryos was performed according to Kaufman (48). Individual somites and early vertebral condensations were identified according to Spörle and Schughart (49). The murine EST of the IMAGE Consortium [CloneID 337300, partial sequence under accession no. W20732; (22)] was obtained from the Human Genome Mapping Project-Resource Centre (HGMP-RC, Cambridge, UK). The zebrafish EST (ICRFp524N033, partial sequence under accession nos AA497316 and AA497240) was kindly provided by Dr M. Clark (Resource Centre of the German Human Genome Project at the Max-Planck-Institute for Molecular Genetics, Berlin, Germany). The 0.6 kb EcoRI-NotI insert of the IMAGE Consortium CloneID 337300 was labelled with [[alpha]-32P]dCTP (Amersham, Braunschweig, Germany) by random priming using the Megaprime DNA labelling system (Amersham) to screen a mouse embryonic day 11 cDNA library of the mouse strain SwissWebster (Novagen, Madison, WI) using stringent hybridization conditions (50% formamide, 5× SSC, 5× Denhardts, 0.1% SDS, 100 µg/ml herring sperm DNA, 42°C). Filters (Qiabrane Nylon; Qiagen, Hilden, Germany) were washed in 0.1× SSC/0.1% SDS at 50°C. Sixteen positive clones were isolated and subcloned into pSHlox-1 by in vivo excision. Both strands of the largest clone (7-3-3, 2.3 kb) were sequenced. To obtain the 5[prime] region, a second mouse embryonic day 11 cDNA library of the mouse strain SwissWebster (kindly provided by Dr G. Borsani, TIGEM, Milano, Italy) was screened using a 935 bp fragment (EcoRI-NdeI) of the 5[prime] end of clone 7-3-3 as a probe. One of the isolated clones (6-1), revealing a 1.9 kb insert, exhibited further 5[prime]-coding region of Hic1 and was subcloned into the EcoRI sites of pBluescript KS and sequenced (Sequiserve, Vaterstetten, Germany). A genomic Hic1 clone was isolated by screening a genomic [lambda]DASH DNA library of the mouse strain 129/SV (50) using the 935 bp EcoRI-NdeI fragment of the 5[prime] region of clone 7-3-3 as a probe. One positive clone (G6-2), containing an ~16 kb insert, was further analyzed. An ~6 kb BamHI fragment of this clone was subcloned into pBluescript KS and sequenced. Sequence analyses were performed with Gene works 2.45N, clustalW 1.7, MatInspector V2.2 (25) (http://www.gsf.de/biodv/ ) and the BLAST network service (51). Total RNA from frozen tissues was isolated with RNeasy (Qiagen). Twenty micrograms of total RNA were separated on a 1% agarose gel according to Sambrook et al. (52), transferred onto nylon membranes (Qiabrane Nylon Plus; Qiagen) and UV crosslinked (Stratalinker; Stratagene, Heidelberg, Germany). The 0.6 kb EcoRI-NotI insert of the IMAGE Consortium CloneID 337300 was labelled with [[alpha]-32P]dCTP (Amersham). Labelling and hybridization was performed as described above. Filters were exposed to X-ray film (Kodak XAR; Eastman Kodak Company, New York, NY) at -80°C with two intensifying screens for 3 days. FISH was performed on metaphase chromosome preparations obtained from mouse bone marrow cells according to standard procedures. The ~16 kb genomic Hic1 clone G6-2 in [lambda]DASH was labelled with biotin-dUTP using the Bio-Prime DNA Labelling System (Gibco BRL, Eggenstein, Germany). The specific chromosome 11 paint probe was obtained from Appligene Oncor; (Heidelberg, Germany). Hybridizations were performed according to Pinkel et al. (53). Metaphase chromosomes were analyzed under an Axiophot microscope (Zeiss, Germany), and pictures were taken by digitizing the microscopic image with the computer program ISIS3 (Metasystems, Altlußheim, Germany) and adapted in Adobe Photoshop 3.0. Genomic DNA samples from the EUCIB were obtained from the HGMP-RC (28). A polymorphism between M.spretus and C57BL/6J was detected in the 3[prime]-UTR of Hic1 using the primer pair 5[prime]-aaccctgcctctccctgtggc-3[prime]/5[prime]-gtagggctgggagcgtcc-3[prime]. To confine the amplified products, the PCR fragments of M.spretus and C57BL/6J were cloned into the pCR[trade]2.1 vector (Invitrogen, Leek, The Netherlands) and sequenced. A 99 bp fragment was amplified from C57BL/6J and a 95 bp fragment from M.spretus. PCR was run in a GeneAmp PCR System 9600 (Perkin Elmer, Weiterstadt, Germany) using the following conditions: 6 min 94°C, 30 cycles of 94, 60 and 72°C each step lasted for 30 s and a final extension step for 10 min at 72°C. For each PCR reaction, 20 ng genomic DNA, 2 U Taq polymerase (Gibco BRL) 1× Taq reaction buffer (Boehringer Mannheim, Germany), 200 µM of each dNTP (Boehringer Mannheim), 1.5 mM MgCl2, 0.25 µM of each oligonucleotide in a total volume of 20 µl were used. Bands were separated on an 8% polyacrylamide/1× TBE gel. A total of 130 backcross animals were typed for the Hic1 locus. Genetic linkage to EUCIB anchor loci was analysed using the Mbx program (28). RNA probes labelled with Digoxigenin-rUTP (Boehringer Mannheim) were synthesized from linearized cDNA templates according to the manufacturers instructions. The IMAGE Consortium CloneID 337300 was linearized with EcoRI and NotI, and synthesized with T3 and T7 RNA polymerases for antisense and sense probes, respectively. The clone 7-3-3 was linearized with SacI and transcribed with SP6 RNA polymerase for the antisense probe. The Myod1 and the Col2a1 probes were previously described (54,55). ISHs of whole mount embryos (WISHs) were performed according to Wilkinson (56) and Rosen and Beddington (57) with modifications described by Spörle and Schughart (58). WISH embryos were cut transversely with a scalpel, and section planes were documented. Staining of WISH embryos by precipitating BM Purple AP Substrate (Boehringer Mannheim) with some riboprobes yielded two different colours in the same reaction. In WISHs, bright blue instead of purple precipitates were observed in the expression territories of Hic1 that were situated medially to the hypaxial somitic buds (Fig. ISHs on paraffin sections were performed as previously described (59,60) with the following modifications. After fixation, embryos were dehydrated in isopropanol, transferred to Histowax saturated with isopropanol and embedded in Histowax (Cambridge Instruments, Nußloch, Germany). Slides were fixed for 30 min at room temperature in both 4% PFA/PBS prehybridization fixation steps, and treated for 3 min with 2 µg/ml proteinase K in 1 mM EDTA, 20 mM Tris-HCl (pH 7.0). Before hybridization, the slides were washed twice for 2 min in 2× SSC, and incubated for at least 30 min in 0.1 M Tris, 0.1 M glycine. Hybridization solution (60 µl/slide) contained 50% formamide, 5× SSC, 5% dextran sulfate, 2 mg/ml heparin, 100 µg/ml tRNA, 0.1% Tween-20 (pH adjusted with citric acid to 6.0) and a 1:100 or 1:50 dilution of the riboprobes. Riboprobes were the same as for WISH. Hybridization occurred overnight at 65°C under a siliconized coverslip or a parafilm strip. Following hybridization, slides were washed for 1-2 h in 0.5× SSC, 20% formamide at 65°C. Sections were treated with 10 µg/ml RNaseA for 30 min at 37°C in NTE (0.5 M NaCl, 5 mM EDTA, 10 mM Tris-HCl, pH 7.0-7.5), then washed for 4 h in 0.5× SSC, 20% formamide at 65°C and for 30 min in 2× SSC, and blocked for 1 h at room temperature in 1% blocking reagent (Boehringer Mannheim)in MAB-T (0.1 M maleic acid, 0.15 M NaCl, 0.1% Tween-20,pH 7.5). A 1:5000 dilution of anti-digoxigenin-AP conjugate (Boehringer Mannheim) was preincubated for at least 1 h in 1% blocking reagent in MAB-T at 4°C. Slides were incubated with the antibody overnight at 4°C, washed for 6 h in TBS-T, for 30 min in NTM-T (0.1 M NaCl, 50 mM MgCl2, 0.1 M Tris-HCl, pH 9.5, 0.1% Tween-20), and stained using centrifuged BM purple AP substrate (Boehringer Mannheim) in 0.3% Tween-20 for 1-7 days at 4°C and/or room temperature. Slides were washed in NTM-T, then in distilled water, and embedded in KAISERS glycerol gelatin (Merck, Darmstadt, Germany). Sections were analysed under a Zeiss Axioplan microscope and documented with a high resolution CCD colour camera (Fujix HC-2000; Fuji) connected to an Apple PowerMacintosh. Pictures were adjusted for brightness, contrast and colour balance in Adobe Photoshop3.0. The authors thank Drs J. Favor, K. Imai and T. Immervoll as well as N. Klopp for helpful discussions. Oligonucleotides were synthesized at the BIODV unit at the GSF by Utz Linzner. The Col2a1 probe was kindly provided by Dr K.S. Cheah (Department of Biochemistry, University of Hong Kong, China) and the Myod1 probe was obtained from Dr R.L. Davis (Department of Genetics, Hutchinson Cancer Research Center, Seattle, Washington, DC). An aliquot from an E11-mouse cDNA library was kindly provided by Dr G. Borsani (TIGEM, Milano, Italy). The genomic [lambda]DASH DNA library of the mouse strain 129/SV was a gift of Dr A.G. Reaume (Cephalon Inc., West Chester, PA). The zebrafish EST ICRFp524N033 was obtained from Dr M. Clark (Resource Centre of the German Human Genome Project at the Max-Planck-Institute for Molecular Genetics, Berlin, Germany). BTB, broad complex, tramtrack, bric à brac; EST, expressed sequence tag; EUCIB, European Collaborative Interspecific Backcross; [gamma]FBP, [gamma]F-crystallin binding protein; HIC1, hypermetylated in cancer 1; hzp1, hypermethylated in cancer, zinc-finger, POZ-domain 1; ILS, isolated lissencephaly sequence; LIS1/PAFAH1B1, lissencephaly 1/platelet activating factor acetyl hydrolase 45 kDa subunit; MDS, Miller-Dieker syndrome; MGD, Mouse Genome Database; MNT/ROX, MAX-interactor protein; p.c., post coitum; POZ, poxvirus and zinc finger; TS, Theiler stage; ZIN, zinc-finger N-terminal domain. After submission of the revised manuscript, the corrected sequence of the human HIC1 gene and its genomic structure was published (GenBank accession no. L41919). The correct human HIC1 sequence and its deduced protein sequence support the results obtained for the murine Hic1 reported here.
Chromosomal localization of Hic1
Expression of the murine Hic1 mRNA
Hic1 expression in sclerotomal and body wall mesenchymes
Expression of Hic1 in limb and cranio-facial mesenchymes
Expression of Hic1 in mesenchymes facing epithelia of inner organs
DISCUSSION
Genomic organization of murine Hic1
Chromosomal localization of Hic1
Comparison of the expressions of Hic1 and [gamma]FBP during development
Hic1 is expressed in perineural mesenchymes
Hic1 is activated in embryonic anlagen of tissues that are affected in MDS patients
MATERIALS AND METHODS
Animals and embryos
Expressed sequence tags
Isolation of the murine Hic1
Northern analysis
Chromosomal localization
In situ hybridization
ACKNOWLEDGEMENTS
ABBREVIATIONS
NOTE ADDED IN PROOF
REFERENCES
This article has been cited by other articles:
This page is run by Oxford University Press, Great Clarendon Street, Oxford OX2 6DP, as part of the OUP Journals
Comments and feedback: www-admin{at}oup.co.uk
Last modification: 10 Mar 1999
Copyright©Oxford University Press, 1999.
![]()
CiteULike
Connotea
Del.icio.us What's this?
![]()
![]()

![]()
![]()
![]()
K. Ganguly, M. Depner, C. Fattman, K. Bein, T. D. Oury, S. C. Wesselkamper, M. T. Borchers, M. Schreiber, F. Gao, E. von Mutius, et al.
Superoxide dismutase 3, extracellular (SOD3) variants and lung function
Physiol Genomics,
May 13, 2009;
37(3):
260 - 267.
[Abstract]
[Full Text]
[PDF]
![]()
![]()
![]()

![]()
![]()
![]()
A. M. Comi, P. Mehta, L. A. Hatfield, and M. M. Dowling
Sturge-Weber Syndrome Associated With Other Abnormalities: A Medical Record and Literature Review
Arch Neurol,
December 1, 2005;
62(12):
1924 - 1927.
[Abstract]
[Full Text]
[PDF]
![]()
![]()
![]()

![]()
![]()
![]()
S. Pinte, N. Stankovic-Valentin, S. Deltour, B. R. Rood, C. Guerardel, and D. Leprince
The Tumor Suppressor Gene HIC1 (Hypermethylated in Cancer 1) Is a Sequence-specific Transcriptional Repressor: DEFINITION OF ITS CONSENSUS BINDING SEQUENCE AND ANALYSIS OF ITS DNA BINDING AND REPRESSIVE PROPERTIES
J. Biol. Chem.,
September 10, 2004;
279(37):
38313 - 38324.
[Abstract]
[Full Text]
[PDF]
![]()
![]()
![]()

![]()
![]()
![]()
S. Deltour, S. Pinte, C. Guerardel, B. Wasylyk, and D. Leprince
The Human Candidate Tumor Suppressor Gene HIC1 Recruits CtBP through a Degenerate GLDLSKK Motif
Mol. Cell. Biol.,
July 1, 2002;
22(13):
4890 - 4901.
[Abstract]
[Full Text]
[PDF]
![]()
![]()
![]()

![]()
![]()
![]()
J. Lengler, E. Krausz, S. Tomarev, A. Prescott, R. A. Quinlan, and J. Graw
Antagonistic action of Six3 and Prox1 at the {{gamma}}-crystallin promoter
Nucleic Acids Res.,
January 15, 2001;
29(2):
515 - 526.
[Abstract]
[Full Text]
[PDF]
![]()
![]()
![]()

![]()
![]()
![]()
M. G. Carter, M. A. Johns, X. Zeng, L. Zhou, M. C. Zink, J. L. Mankowski, D. M. Donovan, and S. B. Baylin
Mice deficient in the candidate tumor suppressor gene Hic1 exhibit developmental defects of structures affected in the Miller-Dieker syndrome
Hum. Mol. Genet.,
February 12, 2000;
9(3):
413 - 419.
[Abstract]
[Full Text]
[PDF]
![]()
![]()
![]()

![]()
![]()
![]()
S. Deltour, C. Guerardel, and D. Leprince
Recruitment of SMRT/N-CoR-mSin3A-HDAC-repressing complexes is not a general mechanism for BTB/POZ transcriptional repressors: The case of HIC-1 and gamma FBP-B
PNAS,
December 21, 1999;
96(26):
14831 - 14836.
[Abstract]
[Full Text]
[PDF]
![]()
![]()
![]()

![]()
![]()
![]()
M. E. Hoatlin, Y. Zhi, H. Ball, K. Silvey, A. Melnick, S. Stone, S. Arai, N. Hawe, G. Owen, A. Zelent, et al.
A Novel BTB/POZ Transcriptional Repressor Protein Interacts With the Fanconi Anemia Group C Protein and PLZF
Blood,
December 1, 1999;
94(11):
3737 - 3747.
[Abstract]
[Full Text]
[PDF]
![]()
![]()
![]()

![]()
![]()
![]()
C. Guerardel, S. Deltour, S. Pinte, D. Monte, A. Begue, A. K. Godwin, and D. Leprince
Identification in the Human Candidate Tumor Suppressor Gene HIC-1 of a New Major Alternative TATA-less Promoter Positively Regulated by p53
J. Biol. Chem.,
January 26, 2001;
276(5):
3078 - 3089.
[Abstract]
[Full Text]
[PDF]
![]()
This Article ![]()
![]()
Abstract
![]()
FREE Full Text (PDF)
![]()
Alert me when this article is cited
![]()
Alert me if a correction is posted
![]()
Services ![]()
![]()
Email this article to a friend
![]()
Similar articles in this journal
![]()
Similar articles in ISI Web of Science
![]()
Similar articles in PubMed
![]()
Alert me to new issues of the journal
![]()
Add to My Personal Archive
![]()
Download to citation manager
![]()
Search for citing articles in:
ISI Web of Science (25)
![]()
Request Permissions ![]()
Google Scholar ![]()
![]()
Articles by Grimm, C.
![]()
Articles by Graw, J.
![]()
Search for Related Content
![]()
PubMed ![]()
![]()
PubMed Citation
![]()
Articles by Grimm, C.
![]()
Articles by Graw, J.
![]()
Social Bookmarking ![]()
![]()
What's this?



